1) and Drug Interactions (seven)]. The risk of hypoglycemia could be reduced by a reduction during the dose of sulfonylurea (or other concomitantly administered insulin secretagogue) or insulin. Notify patients working with these concomitant drugs of the potential risk of hypoglycemia and educate them around the indications and signs or symptoms of